Skip to main content
. 2017 Nov 30;12(11):e0188303. doi: 10.1371/journal.pone.0188303

Fig 1.

Fig 1

A and B. Different kinetics of qHBsAg in HBeAg-negative CHB patients receiving NAs. Fig 1A shows the kinetics of qHBsAg (log IU/mL) in patients who did not achieve low levels (>120 IU/mL) during follow-up (n = 82). Fig 1B shows the kinetics of qHBsAg in patients who achieved low levels (<120 IU/mL) during follow-up (n = 10). Using a mathematical mixed model for repeated measurements, the slope in patients who achieved low levels of HBsAg (y = 3.22–0.257x(t)) was significantly greater compared to those who did not (y = 3.66–0.057x(t)) (p <0.001).